Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation

Gastroenterology(2022)10.1053/j.gastro.2022.04.016Source: DataRank Database

AGA Clinical Practice Guideline on the Pharmacological Management of Irritable Bowel Syndrome With Constipation is a research paper published in Gastroenterology (2022). On theSindex it has a DataRank of 0. It has been cited 152 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access152 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 19.95)OA: bronzeTopics (47)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Shahnaz Sultan ORCID,Anthony Lembo ORCID,G. Nicholas Verne ORCID,Walter Smalley ORCID,Joel J. Heidelbaugh

Live enrichment

PubMed:35738724 OpenAlex:https://openalex.org/W4283163096

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK099052

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: DK118959

FWCI

19.95

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttps://www.gastrojournal.org/article/S0016-5085(22)00390-0/pdf

publisherhttps://www.gastrojournal.org/article/S0016-5085(22)00390-0/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0016508522003900?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0016508522003900?httpAccept=text/plain

journalhttps://doi.org/10.1053/j.gastro.2022.04.016

Fields of Study

Gastrointestinal motility and disordersEnhanced Recovery After SurgeryMicroscopic ColitisAntidepressive Agents, TricyclicConstipationGastrointestinal AgentsHumansIrritable Bowel SyndromeLaxativesLubiprostoneParasympatholyticsPolyethylene GlycolsSelective Serotonin Reuptake Inhibitors

MeSH Terms

LubiprostoneAntidepressive Agents, TricyclicConstipationGastrointestinal AgentsHumansParasympatholyticsPolyethylene GlycolsSelective Serotonin Reuptake InhibitorsIrritable Bowel SyndromeLaxatives

Keywords

Irritable bowel syndromeGuidelineConstipationMedicineClinical PracticeIntensive care medicineGastroenterologyInternal medicinePhysical therapyPathologyAntispasmodicLinaclotideLubiprostoneMeta-AnalysisPlecanatidePolyethylene GlycolQuality of LifeRandomized Controlled TrialSelective Serotonin Reuptake InhibitorSymptomsTegaserodTenapanorTreatmentTricyclic Antidepressant